Pulmonology
Clinical evidence related to single-use bronchoscopy
Explore clinical evidence, articles and other information related to bronchoscopy and our single-use bronchoscope solutions.
FDA Recommends Single-Use Bronchoscopes
In a new safety communication, the FDA substantiates reusable bronchoscope associated cross-infections. To alleviate the cross-infection risk, the FDA recommends introducing a sterilization step during the reprocessing of reusable flexible bronchoscopes and that single-use bronchoscopes must be considered when there is an increased risk of spreading infection.
Our white paper explores the implications of these new recommendations and demonstrates the impact these have on patient safety, costs, workflow complexity and turnaround time.
New Study: Single-Use Bronchoscopes Can Cut Hospital Readmissions by 53%
Hospitals that perform bronchoscopies can reduce readmission rates by over half, and potentially lower costs, by adopting single-use flexible bronchoscopes. That’s according to a new abstract that was submitted and presented at the recently completed CHEST 2021 Annual Meeting.
Evidence
Evaluation of closed-loop system vs standard sampling solutions
In this article, Respiratory consultant, Dr. Suveer Singh, presents the results of his evaluation of Ambu® aScope™ BronchoSampler™. The evaluation was based on procedures performed at Royal Brompton and Chelsea and Westminster hospitals in the UK.
More effective for collecting and protecting samples
The results of the analysis were published on Karger.com. Prof. Pallav L. Shah reviewed the data and co-edited the manuscript. Among other conclusions, Dr. Singh found that aScope BronchoSampler:
- Is quicker, easier and more effective than standard sampling solutions
- Offers a possibly safer technique for diagnostic sampling in the ICU
- May improve safety standards during the coronavirus pandemic
